Using circulating tumor DNA in lymphoma: clinical trials & clinical practice [Video]

In this video, Ash Alizadeh, MD, PhD, Stanford Comprehensive Cancer Center, Stanford, CA, comments on the use of circulating tumor DNA (ctDNA) in lymphoma. This non-invasive diagnostic tool may be used in the future for patient selection, risk stratification, and as a surrogate endpoint to monitor responses to treatment. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.